Michael A Traver
Author pages are created from data sourced from our academic publisher partnerships and public sources.
Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
- R. Zagoria, Michael A Traver, David M Werle, M. Perini, S. Hayasaka, P. Clark
- AJR. American journal of roentgenology
- 1 August 2007
OBJECTIVE A single institution's experience with CT-guided percutaneous radiofrequency ablation of biopsy-proven renal cell carcinomas (RCCs) was studied to determine the disease-free survival and… Expand
New generation tissue sealants and hemostatic agents: innovative urologic applications.
Control of blood loss during urologic surgery is paramount to the success of patient recovery. Hemostatic agents and tissue sealants are used routinely to prevent excess blood loss and in… Expand
Radical retropubic cystectomy
Open radical cystectomy (RC) remains the treatment of choice for patients who present with invasive disease, those with progressive disease, or disease refractory to intravesical therapy . Older… Expand